Dialectic Therapeutics

About:

Dialectic Therapeutics is a biotechnology company focused on creating innovative new technologies to end cancer.

Website: https://www.dtsciences.com/

Top Investors: Cancer Prevention and Research Institute of Texas

Description:

Dialectic Therapeutics (DT) is a pre-clinical biotechnology company dedicated to the development of unique, impactful anti-cancer drugs that effectively treat patients with few to no other options. The company's drugs selectively induce cancer cells to degrade B-cell lymphoma and stimulate the cells to commit suicide or become susceptible to chemotherapy, enabling patients to have increased disease-free survival. Dialectic Therapeutics was founded in 2018 and is located in Dallas, Texas.